Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers

URN to cite this document:: urn:nbn:de:bvb:355-epub-530981
DOI to cite this document:: 10.5283/epub.53098

Ettl, Tobias

; Grube, Matthias ; Schulz, Daniela

; Bauer, Richard J.

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 24 Oct 2022 06:39

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Recently, considerable progress has been achieved in cancer immunotherapy. Targeted immune checkpoint therapies have been established for several forms of cancers, which resulted in a tremendous positive impact on patient survival, even in more advanced tumor stages. With a better understanding of cellular responses to immune checkpoint therapies, it will soon be feasible to find targeted ...